{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:18:29Z","timestamp":1784301509942,"version":"3.55.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.earlhumdev.2025.106389","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:36:47Z","timestamp":1757140607000},"page":"106389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Optimizing antenatal corticosteroid therapy: Balancing benefit and risk in the era of precision medicine"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3128-0572","authenticated-orcid":false,"given":"Hannah R.S.","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2025.106389_bb0005","series-title":"Antenatal corticosteroids for fetal lungmaturation: an overview of Cochrane reviews","author":"McGoldrick","year":"2016"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0010","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10409","key":"10.1016\/j.earlhumdev.2025.106389_bb0015","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","article-title":"National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis","volume":"402","author":"Ohuma","year":"2023","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.earlhumdev.2025.106389_bb0020","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod. Health"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/adc.2005.090308","article-title":"Socioeconomic inequalities in very preterm birth rates","volume":"92","author":"Smith","year":"2007","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","article-title":"The preterm parturition syndrome","volume":"113","author":"Romero","year":"2006","journal-title":"BJOG"},{"issue":"9606","key":"10.1016\/j.earlhumdev.2025.106389_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2018.04.003","article-title":"The global epidemiology of preterm birth","volume":"52","author":"Vogel","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S2213-2600(21)00508-7","article-title":"Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study","volume":"10","author":"Bui","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.earlhumdev.2025.106389_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/fn.85.3.F159","article-title":"Outcome at 14 years of extremely low birthweight infants: a regional study","volume":"85","author":"Doyle","year":"2001","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"3","key":"10.1016\/j.earlhumdev.2025.106389_bb0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajog.2023.09.013","article-title":"Antenatal corticosteroids: an updated assessment of anticipated benefits and potential risks","volume":"230","author":"Jobe","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0060","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1677\/joe.0.0450515","article-title":"Premature delivery of foetal lambs infused with glucocorticoids","volume":"45","author":"Liggins","year":"1969","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"issue":"80\u20138","key":"10.1016\/j.earlhumdev.2025.106389_bb0070","article-title":"Betamethasone for preterm birth: Auckland steroid trial full results and new insights 50 years on","volume":"255","author":"Walters","year":"2023","journal-title":"J. Pediatr."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0075","series-title":"Antenatal Corticosteroids Given to Women Prior to Birth to Improve Fetal, Infant, Child and Adult Health: Clinical Practice Guidelines","author":"Zealand N. Australia Antenatal Corticosteroid Clinical Practice Guidelines Panel","year":"2015"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0080","article-title":"Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth","volume":"8","author":"Brownfoot","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajog.2018.04.007","article-title":"Antenatal corticosteroids: an assessment of anticipated benefits and potential risks","volume":"219","author":"Jobe","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0090","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"12","author":"McGoldrick","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0095","doi-asserted-by":"crossref","DOI":"10.4103\/singaporemedj.SMJ-2025-040","article-title":"Adopting a consensus on the dose of antenatal steroids used by obstetric and neonatal services in Singapore in anticipation of imminent preterm birth","author":"Kemp","year":"2025","journal-title":"Singapore Med. J."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0100","series-title":"WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes","year":"2022"},{"issue":"8","key":"10.1016\/j.earlhumdev.2025.106389_bb0105","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/1471-0528.17027","article-title":"Antenatal corticosteroids to reduce neonatal morbidity and mortality: green-top guideline No. 74","volume":"129","author":"Stock","year":"2022","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0110","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2022.2160628","article-title":"European guidelines on perinatal care: corticosteroids for women at risk of preterm birth","volume":"36","author":"Daskalakis","year":"2023","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0115","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/AOG.0000000000002356","article-title":"Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation (vol 130, pg e102, 2017)","volume":"130","author":"Obstet AC","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.11.057","article-title":"41: Fetal metabolic biomarkers after late preterm betamethasone and their association with neonatal hypoglycemia","volume":"222","author":"Battarbee","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.earlhumdev.2025.106389_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2021-322152","article-title":"Antenatal corticosteroids and neurodevelopmental outcomes in late preterm births","volume":"107","author":"Aviram","year":"2022","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0130","article-title":"Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes","volume":"12","author":"Sotiriadis","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0135","doi-asserted-by":"crossref","DOI":"10.1067\/mob.2003.384","article-title":"Pregnancy outcomes associated with intrauterine growth restriction","volume":"188","author":"Gilbert","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jpeds.2022.09.050","article-title":"Antenatal corticosteroid exposure is associated with childhood mental disorders in late preterm and term infants","volume":"253","author":"Lin","year":"2023","journal-title":"J. Pediatr."},{"issue":"19","key":"10.1016\/j.earlhumdev.2025.106389_bb0145","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2020.3937","article-title":"Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children","volume":"323","author":"Raikkonen","year":"2020","journal-title":"Jama-J Am Med Assoc."},{"issue":"12","key":"10.1016\/j.earlhumdev.2025.106389_bb0150","first-page":"1102","article-title":"Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5)","volume":"167","author":"Asztalos","year":"2013","journal-title":"JAMA Pediatr."},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0155","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1542\/peds.102.5.1116","article-title":"Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids","volume":"102","author":"Jobe","year":"1998","journal-title":"Pediatrics"},{"issue":"9656","key":"10.1016\/j.earlhumdev.2025.106389_bb0160","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(08)61929-7","article-title":"Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial","volume":"372","author":"Murphy","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076035","article-title":"The proportions of term or late preterm births after exposure to early antenatal corticosteroids, and outcomes: systematic review and meta-analysis of 1.6 million infants","volume":"382","author":"Ninan","year":"2023","journal-title":"BMJ"},{"issue":"10352","key":"10.1016\/j.earlhumdev.2025.106389_bb0170","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(22)01535-5","article-title":"Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial","volume":"400","author":"Schmitz","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2022.0483","article-title":"Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis","volume":"176","author":"Ninan","year":"2022","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0180","series-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"4","author":"Roberts","year":"2007"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0185","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jpeds.2010.12.039","article-title":"Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation","volume":"159","author":"Mori","year":"2011","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.11.554","article-title":"Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids","volume":"218","author":"Travers","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.AOG.0000297311.33046.73","article-title":"Neonatal mortality and morbidity rates in late preterm births compared with births at term","volume":"111","author":"McIntire","year":"2008","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0200","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ajog.2011.07.015","article-title":"A systematic review of severe morbidity in infants born late preterm","volume":"205","author":"Teune","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"14","key":"10.1016\/j.earlhumdev.2025.106389_bb0205","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal Betamethasone for Women at Risk for Late Preterm Delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/GRF.0000000000000865","article-title":"Antenatal late preterm steroids: the evolution of the ALPS trial","volume":"67","author":"Gyamfi-Bannerman","year":"2024","journal-title":"Clin. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12702","article-title":"US incidence of late-preterm steroid use and associated neonatal respiratory morbidity after publication of the antenatal late preterm steroids trial, 2015-2017","volume":"5","author":"Clapp","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ajog.2022.03.037","article-title":"The impact of the antenatal late preterm steroids trial on the administration of antenatal corticosteroids","volume":"227","author":"Kearsey","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"19","key":"10.1016\/j.earlhumdev.2025.106389_bb0225","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2024.4303","article-title":"Neurodevelopmental outcomes after late preterm antenatal corticosteroids: the ALPS follow-up study","volume":"331","author":"Gyamfi-Bannerman","year":"2024","journal-title":"JAMA"},{"issue":"7518","key":"10.1016\/j.earlhumdev.2025.106389_bb0230","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/bmj.38547.416493.06","article-title":"Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial","volume":"331","author":"Stutchfield","year":"2005","journal-title":"Bmj"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004454.pub2","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2006","journal-title":"Cochrane Db Syst Rev"},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0240","first-page":"240","article-title":"The clinical use of corticosteroids in pregnancy","volume":"22","author":"Kemp","year":"2016","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0245","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0021-9673(01)00744-0","article-title":"Differentiation between dexamethasone and betamethasone in a mixture using multiple mass spectrometry","volume":"926","author":"De Wasch","year":"2001","journal-title":"J. Chromatogr. A"},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0250","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cts.12724","article-title":"Pharmacokinetics and pharmacodynamics of intramuscular and Oral betamethasone and dexamethasone in reproductive age women in India","volume":"13","author":"Jobe","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0255","series-title":"WHO recommendations on interventions to improve preterm birth outcomes. WHO Guidelines Approved by the Guidelines Review Committee. Geneva","year":"2015"},{"issue":"8","key":"10.1016\/j.earlhumdev.2025.106389_bb0260","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/dmd.105.004309","article-title":"Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use","volume":"33","author":"Samtani","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0265","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ajog.2004.01.044","article-title":"Choice and dose of corticosteroid for antenatal treatments","volume":"190","author":"Jobe","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0270","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41390-020-01249-w","article-title":"Antenatal corticosteroids: a reappraisal of the drug formulation and dose","volume":"89","author":"Jobe","year":"2021","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajog.2022.10.002","article-title":"Updating the balance between benefits and harms of antenatal corticosteroids","volume":"228","author":"Vidaeff","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0280","article-title":"One percent of the clinical dose used for antenatal steroid therapy is sufficient to induce lung maturation when administered directly to the preterm ovine fetus","volume":"322","author":"Fee","year":"2022","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0285","article-title":"Respiratory benefit in preterm lambs is progressively lost when the concentration of fetal plasma betamethasone is titrated below two nanograms per milliliter","volume":"325","author":"Fee","year":"2023","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.08.017","article-title":"Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphate","volume":"215","author":"Kemp","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.earlhumdev.2025.106389_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.05.007","article-title":"The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy","volume":"219","author":"Kemp","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0300","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1038\/s41598-019-45171-6","article-title":"Dosing and formulation of antenatal corticosteroids for fetal lung maturation and gene expression in rhesus macaques","volume":"9","author":"Schmidt","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0305","article-title":"Continuous but not pulsed low-dose fetal betamethasone exposures extend the durability of antenatal steroid therapy","volume":"322","author":"Takahashi","year":"2022","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0310","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ajog.2022.06.058","article-title":"Low-dose antenatal betamethasone treatment achieves preterm lung maturation equivalent to that of the World Health Organization dexamethasone regimen but with reduced endocrine disruption in a sheep model of pregnancy","volume":"227","author":"Usuda","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0315","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpeds.2022.10.028","article-title":"Betamethasone for preterm birth: Auckland steroid trial full results and new insights 50 years on","volume":"255","author":"Walters","year":"2022","journal-title":"J. Pediatr."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0320","series-title":"BETAmethasone dose reduction: non-inferiority on the neurocognitive outcomes of children born before 32 Weeks of Gestation","author":"Assistance Publique \u2013 H\u00f4pitaux de Paris","year":"2024"},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0325","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jogc.2022.02.071","article-title":"Single dose of antenatal corticosteroids (SNACS) non-inferiority randomized controlled trial for pregnancies at risk of preterm delivery","volume":"44","author":"McDonald","year":"2022","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"Suppl. 1","key":"10.1016\/j.earlhumdev.2025.106389_bb0330","first-page":"43","article-title":"Continuous but not pulsed steroid exposures extend the durability of antenatal steroid therapy in a sheep model of pregnancy","volume":"29","author":"Takahashi","year":"2022","journal-title":"Reprod. Sci."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0335","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13063-024-07941-0","volume":"25","year":"2024","journal-title":"Trials"},{"issue":"8","key":"10.1016\/j.earlhumdev.2025.106389_bb0340","article-title":"Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth","volume":"8","author":"Williams","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.earlhumdev.2025.106389_bb0345","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S2352-4642(19)30292-5","article-title":"Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial","volume":"3","author":"Crowther","year":"2019","journal-title":"Lancet Child Adolesc Health."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0350","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0004-8666.2003.00052.x","article-title":"Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review","volume":"43","author":"McLaughlin","year":"2003","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0355","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.11315","article-title":"Timing of antenatal corticosteroid administration and neonatal outcomes","volume":"8","author":"Melamed","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0360","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1471-0528.2010.02751.x","article-title":"Antenatal steroids and neonatal outcome after chorioamnionitis: a meta-analysis","volume":"118","author":"Been","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101916","article-title":"Effect of antenatal corticosteroid administration-to-birth interval on maternal and newborn outcomes: a systematic review","volume":"58","author":"McDougall","year":"2023","journal-title":"Eclinicalmedicine"},{"issue":"7","key":"10.1016\/j.earlhumdev.2025.106389_bb0370","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamapediatrics.2017.0602","article-title":"Association of short antenatal corticosteroid administration-to-birth intervals with survival and morbidity among very preterm infants: results from the EPICE cohort","volume":"171","author":"Norman","year":"2017","journal-title":"JAMA Pediatr."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0375","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.61312","article-title":"Short duration of antenatal corticosteroid exposure and outcomes in extremely preterm infants","volume":"8","author":"Chawla","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"5 Pt 1","key":"10.1016\/j.earlhumdev.2025.106389_bb0380","first-page":"721","article-title":"Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study","volume":"73","author":"Morales","year":"1989","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0385","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ajog.2006.12.018","article-title":"The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study","volume":"196","author":"Ring","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3 Pt 2","key":"10.1016\/j.earlhumdev.2025.106389_bb0390","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ajog.2005.06.050","article-title":"The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes","volume":"193","author":"Peaceman","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0395","article-title":"Effect of dexamethasone on newborn survival at different administration-to-birth intervals: a secondary analysis of the WHO ACTION (antenatal CorticosTeroids for improving outcomes in preterm newborn)-I trial","volume":"53","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0400","first-page":"445","article-title":"Predicting preterm birth: cervical length and fetal fibronectin","volume":"41","year":"2017"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0405","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12978-016-0179-z","article-title":"The antenatal corticosteroids trial (ACT): a secondary analysis to explore site differences in a multi-country trial","volume":"13","author":"Klein","year":"2016","journal-title":"Reprod. Health"},{"issue":"9968","key":"10.1016\/j.earlhumdev.2025.106389_bb0410","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(14)61651-2","article-title":"A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial","volume":"385","author":"Althabe","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0415","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9378(92)91691-3","article-title":"A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 week\u2019s gestation","volume":"166","author":"Garite","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0420","first-page":"186","article-title":"Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant","volume":"50","author":"Block","year":"1977","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0425","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.rbmo.2018.12.001","article-title":"Towards the global coverage of a unified registry of IVF outcomes","volume":"38","author":"Fauser","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0430","series-title":"Organization for Economic co, Development. Age of Mothers at Childbirth and Age-Specific Fertility. Organization for Economic Cooperation and Development Paris, France","year":"2017"},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0435","first-page":"2401","article-title":"Global trends in prevalence of maternal overweight and obesity: a systematic review and meta-analysis of routinely collected data retrospective cohorts","volume":"9","author":"Kent","year":"2024","journal-title":"Int J Popul Data Sci."},{"issue":"10448","key":"10.1016\/j.earlhumdev.2025.106389_bb0440","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(24)00825-0","article-title":"Epidemiology and management of gestational diabetes","volume":"404","author":"Sweeting","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0445","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12884-025-07359-9","article-title":"Effects of antenatal corticosteroid therapy in animal models of fetal growth restriction: a systematic review and meta-analysis","volume":"25","author":"van de Meent","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"10.1016\/j.earlhumdev.2025.106389_bb0450","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/1933719110373148","article-title":"Preterm birth, infection, and inflammation advances from the study of animal models","volume":"17","author":"Kemp","year":"2010","journal-title":"Reprod. Sci."},{"issue":"7","key":"10.1016\/j.earlhumdev.2025.106389_bb0455","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41390-019-0712-1","article-title":"Long-term neuropathological and\/or neurobehavioral effects of antenatal corticosteroid therapy in animal models: a systematic review","volume":"87","author":"van der Merwe","year":"2020","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0460","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ajog.2015.10.022","article-title":"1: antenatal late preterm steroids (ALPS): a randomized trial to reduce neonatal respiratory morbidity","volume":"214","author":"Gyamfi-Bannerman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0465","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075835","article-title":"Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study","volume":"382","author":"Yao","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0470","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003935.pub4","article-title":"Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes","author":"Crowther","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.earlhumdev.2025.106389_bb0475","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031197","article-title":"Neurodevelopmental disorders among term infants exposed to antenatal corticosteroids during pregnancy: a population-based study","volume":"9","author":"Melamed","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0480","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ajog.2012.06.012","article-title":"Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations","volume":"207","author":"Waffarn","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9474","key":"10.1016\/j.earlhumdev.2025.106389_bb0485","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/S0140-6736(05)66617-2","article-title":"Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial","volume":"365","author":"Dalziel","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0490","doi-asserted-by":"crossref","first-page":"e1282","DOI":"10.1542\/peds.2011-3175","article-title":"Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism","volume":"129","author":"Kelly","year":"2012","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0495","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/ppe.12886","article-title":"Little evidence for long-term harm from antenatal corticosteroids in a population-based very low birthweight young adult cohort","volume":"36","author":"Darlow","year":"2022","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0500","doi-asserted-by":"crossref","DOI":"10.1136\/fn.83.2.F154","article-title":"Antenatal steroids and the developing brain","volume":"83","author":"Whitelaw","year":"2000","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0505","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1081\/ERC-120016991","article-title":"Glucocorticoids, hypothalamo-pituitary-adrenal (HPA) development, and life after birth","volume":"28","author":"Matthews","year":"2002","journal-title":"Endocr. Res."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0510","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2012.08.065","article-title":"Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity","volume":"239","author":"Suri","year":"2013","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0515","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1071\/RD9910501","article-title":"Endocrine and substrate control of fetal growth: placental and maternal influences and insulin-like growth factors","volume":"3","author":"Owens","year":"1991","journal-title":"Reprod. Fertil. Dev."},{"issue":"3","key":"10.1016\/j.earlhumdev.2025.106389_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033369","article-title":"Effects of antenatal glucocorticoid therapy on hippocampal histology of preterm infants","volume":"7","author":"Tijsseling","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.earlhumdev.2025.106389_bb0525","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.biopsych.2013.03.009","article-title":"Fetal glucocorticoid exposure is associated with preadolescent brain development","volume":"74","author":"Davis","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0530","first-page":"514","article-title":"Endocrine and paracrine regulation of birth at term and preterm","volume":"21","author":"Challis","year":"2000","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0535","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0002-9378(98)70518-6","article-title":"Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep","volume":"178","author":"Jobe","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0540","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0736-5748(01)00026-0","article-title":"Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep","volume":"19","author":"Huang","year":"2001","journal-title":"Int. J. Dev. Neurosci."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0545","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-3806(90)90002-G","article-title":"Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus","volume":"53","author":"Uno","year":"1990","journal-title":"Dev. Brain Res."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0550","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12916-024-03542-5","article-title":"Antenatal steroids elicited neurodegenerative-associated transcriptional changes in the hippocampus of preterm fetal sheep independent of lung maturation","volume":"22","author":"Carter","year":"2024","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.earlhumdev.2025.106389_bb0555","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2826.2005.01331.x","article-title":"Altered mesencephalic dopaminergic populations in adulthood as a consequence of brief perinatal glucocorticoid exposure","volume":"17","author":"McArthur","year":"2005","journal-title":"J. Neuroendocrinol."},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0560","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000127146","article-title":"Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat","volume":"64","author":"Levitt","year":"1996","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0565","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ajog.2022.06.058","article-title":"Low-dose antenatal betamethasone treatment achieves preterm lung maturation equivalent to that of the WHO dexamethasone regimen but with reduced endocrine disruption in a sheep model of pregnancy","volume":"227","author":"Usuda","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0570","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/cs0980137","article-title":"Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children","volume":"98","author":"Doyle","year":"2000","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0575","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13063-019-3488-z","volume":"20","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0580","article-title":"Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study","volume":"356","author":"Travers","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0585","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0002-9378(95)90223-6","article-title":"Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: discussion","volume":"173","author":"Sinclair","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0590","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jama.2010.1015","article-title":"Respiratory morbidity in late preterm births","volume":"304","author":"Consortium","year":"2010","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.earlhumdev.2025.106389_bb0595","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr."},{"issue":"3","key":"10.1016\/j.earlhumdev.2025.106389_bb0600","doi-asserted-by":"crossref","first-page":"F195","DOI":"10.1136\/archdischild-2012-303157","article-title":"Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial)","volume":"98","author":"Stutchfield","year":"2013","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0605","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ajog.2010.04.031","article-title":"Twins: prevalence, problems, and preterm births","volume":"203","author":"Chauhan","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0610","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12884-018-2082-9","article-title":"Perinatal outcomes in twin pregnancies complicated by maternal morbidity: evidence from the WHO multicountry survey on maternal and newborn health","volume":"18","author":"Santana","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0615","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajog.2016.05.037","article-title":"The role of antenatal corticosteroids in twin pregnancies complicated by preterm birth","volume":"215","author":"Melamed","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0620","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1080\/14767058.2017.1297408","article-title":"Effect of antenatal corticosteroids on morbidity and mortality of preterm singletons and twins","volume":"31","author":"Vaz","year":"2018","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"9","key":"10.1016\/j.earlhumdev.2025.106389_bb0625","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/1471-0528.15014","article-title":"Efficacy of antenatal corticosteroids in preterm twins: the EPIPAGE-2 cohort study","volume":"125","author":"Palas","year":"2018","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0630","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1186\/s12884-022-05262-1","article-title":"Late preterm antenatal corticosteroids in singleton and twin gestations: a retrospective cohort study","volume":"22","author":"Vieira","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"11","key":"10.1016\/j.earlhumdev.2025.106389_bb0635","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.43781","article-title":"Antenatal corticosteroid treatment during the late-preterm period and neonatal outcomes for twin pregnancies","volume":"6","author":"Zhu","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0640","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1067\/mob.2002.123891","article-title":"Cohort study of the neonatal outcome of twin pregnancies that were treated with prophylactic or rescue antenatal corticosteroids","volume":"187","author":"Murphy","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0645","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-078778","article-title":"Randomised placebo-controlled trial of antenatal corticosteroids for planned birth in twins (STOPPIT-3): study protocol","volume":"14","author":"Murray","year":"2024","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0650","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12916-025-03910-9","article-title":"Single-nucleotide polymorphisms in dizygotic twin ovine fetuses are associated with discordant responses to antenatal steroid therapy","volume":"23","author":"Fee","year":"2025","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.05.032","article-title":"Variability in the efficacy of a standardized antenatal steroid treatment was independent of maternal or fetal plasma drug levels: evidence from a sheep model of pregnancy","volume":"223","author":"Takahashi","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0660","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.reprotox.2020.10.005","article-title":"Intrauterine growth restriction: clinical consequences on health and disease at adulthood","volume":"99","author":"Armengaud","year":"2021","journal-title":"Reprod. Toxicol."},{"issue":"7","key":"10.1016\/j.earlhumdev.2025.106389_bb0665","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1440-1681.2008.04975.x","article-title":"Sheep models of intrauterine growth restriction: fetal adaptations and consequences","volume":"35","author":"Morrison","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0670","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/1933719109332821","article-title":"Antenatal glucocorticoid treatment of the growth-restricted fetus: benefit or cost?","volume":"16","author":"Morrison","year":"2009","journal-title":"Reprod. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.earlhumdev.2025.106389_bb0675","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0301-2115(03)00170-2","article-title":"Models of fetal growth restriction","volume":"110","author":"Schroder","year":"2003","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"10.1016\/j.earlhumdev.2025.106389_bb0680","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000263348","article-title":"Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses","volume":"3","author":"Economides","year":"1988","journal-title":"Fetal Ther."},{"issue":"1 Pt 1","key":"10.1016\/j.earlhumdev.2025.106389_bb0685","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9378(00)70513-8","article-title":"Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford network","volume":"182","author":"Bernstein","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0690","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9378(16)33697-3","article-title":"Conversion of maternal cortisol to cortisone during placental transfer to the human fetus","volume":"118","author":"Murphy","year":"1974","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.earlhumdev.2025.106389_bb0695","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/endo.142.7.8238","article-title":"The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero","volume":"142","author":"Bertram","year":"2001","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.earlhumdev.2025.106389_bb0700","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1210\/jc.2002-020310","article-title":"Oxygen regulation of placental 11 beta-hydroxysteroid dehydrogenase 2: physiological and pathological implications","volume":"87","author":"Alfaidy","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0705","first-page":"706","article-title":"Antenatal dexamethasone: effect on ovine placental 11beta-hydroxysteroid dehydrogenase type 2 expression and fetal growth","volume":"52","author":"Kerzner","year":"2002","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.earlhumdev.2025.106389_bb0710","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.reprotox.2012.01.013","article-title":"Maternal undernutrition reduces P-glycoprotein in guinea pig placenta and developing brain in late gestation","volume":"33","author":"Soo","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0715","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/839656","article-title":"Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?","volume":"2012","author":"Morrison","year":"2012","journal-title":"J. Pregnancy"},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0720","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1164\/ajrccm.156.1.9612036","article-title":"Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs","volume":"156","author":"Ikegami","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3S","key":"10.1016\/j.earlhumdev.2025.106389_bb0725","article-title":"Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment","volume":"230","author":"Jung","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.earlhumdev.2025.106389_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11112922","article-title":"Chorioamnionitis: An update on diagnostic evaluation","volume":"11","author":"Carter","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0735","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis","volume":"37","author":"Tita","year":"2010","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0740","doi-asserted-by":"crossref","DOI":"10.1017\/S2040174425000078","article-title":"A review of the potential off-target effects of antenatal steroid exposures on fetal development","volume":"16","author":"Carter","year":"2025","journal-title":"J. Dev. Orig. Health Dis."},{"issue":"10","key":"10.1016\/j.earlhumdev.2025.106389_bb0745","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.clinthera.2011.09.009","article-title":"Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review","volume":"33","author":"Sarnes","year":"2011","journal-title":"Clin. Ther."},{"issue":"9","key":"10.1016\/j.earlhumdev.2025.106389_bb0750","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065070","article-title":"Antenatal corticosteroids in specific groups at risk of preterm birth: a systematic review","volume":"13","author":"Saito","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0755","series-title":"National Clinical Practice Guideline: Antenatal corticosteroids to reduce neonatal morbidity and mortality","author":"Murphy","year":"2024"},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0760","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075835","article-title":"Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study","volume":"382","author":"Yao","year":"2023","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.earlhumdev.2025.106389_bb0765","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139452","article-title":"Prenatal inflammation enhances antenatal corticosteroid-induced fetal lung maturation","volume":"5","author":"Schmidt","year":"2020","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.earlhumdev.2025.106389_bb0770","first-page":"L380","article-title":"Intra-amniotic LPS and antenatal betamethasone: inflammation and maturation in preterm lamb lungs","volume":"302","author":"Kuypers","year":"2012","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"22","key":"10.1016\/j.earlhumdev.2025.106389_bb0775","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1080\/14767058.2019.1689945","article-title":"Histological chorioamnionitis and risk of pulmonary complications in preterm births: a systematic review and meta-analysis","volume":"34","author":"Sarno","year":"2021","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"7","key":"10.1016\/j.earlhumdev.2025.106389_bb0780","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1007\/s43032-025-01876-w","article-title":"Predictive screening for inflammatory disorders of pregnancy using targeted maternal cell-free RNA assays: proof-of-principle data from large animal and human cohorts","volume":"32","author":"Carter","year":"2025","journal-title":"Reprod. Sci."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0785","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12916-025-04256-y","article-title":"Maternal plasma cell-free RNA as a predictive test for fetal lung maturation","volume":"23","author":"Carter","year":"2025","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0790","doi-asserted-by":"crossref","first-page":"18971","DOI":"10.1038\/s41598-021-98587-4","article-title":"Vaginal microbiome as a tool for prediction of chorioamnionitis in preterm labor: a pilot study","volume":"11","author":"Urushiyama","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.earlhumdev.2025.106389_bb0795","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajog.2020.02.037","article-title":"A new rapid bedside test to diagnose and monitor intraamniotic inflammation in preterm PROM using transcervically collected fluid","volume":"223","author":"Oh","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.earlhumdev.2025.106389_bb0800","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13063-024-07941-0","volume":"25","year":"2024","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.earlhumdev.2025.106389_bb0805","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/AOG.0b013e31824ea4b2","article-title":"Antenatal steroids for treatment of fetal lung immaturity after 34 weeks of gestation: an evaluation of neonatal outcomes","volume":"119","author":"Kamath-Rayne","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.earlhumdev.2025.106389_bb0810","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ajog.2008.09.191","article-title":"164: Antenatal steroids for enhancement of fetal lung maturity after 34 weeks: lung maturity and antenatal steroids (LUMAS) study","volume":"199","author":"Shanks","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0815","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejogrb.2021.01.025","article-title":"Fetal lung maturity assessment: a historic perspective and non - invasive assessment using an automatic quantitative ultrasound analysis (a potentially useful clinical tool)","volume":"258","author":"Ahmed","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.earlhumdev.2025.106389_bb0820","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ajog.2017.03.016","article-title":"Prediction of neonatal respiratory morbidity by quantitative ultrasound lung texture analysis: a multicenter study","volume":"217","author":"Palacio","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"16","key":"10.1016\/j.earlhumdev.2025.106389_bb0825","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164895","article-title":"Prediction of neonatal respiratory morbidity assessed by quantitative ultrasound lung texture analysis in twin pregnancies","volume":"11","author":"Moreno-Espinosa","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.earlhumdev.2025.106389_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibtech.2025.06.006","article-title":"Understanding the impact of antenatal corticosteroids via placenta and fetal lung microphysiological analysis platform (MAP) on a chip","author":"Lim","year":"2025","journal-title":"Trends Biotechnol."}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378225001999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378225001999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:58:12Z","timestamp":1769731092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378225001999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":166,"alternative-id":["S0378378225001999"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2025.106389","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing antenatal corticosteroid therapy: Balancing benefit and risk in the era of precision medicine","name":"articletitle","label":"Article Title"},{"value":"Early Human Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2025.106389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106389"}}